In NAFLD patients, concentrations of adiponectin are decreased whereas leptin levels are increased, indicating an imbalance of adipocytokines, which might promote the progression of this liver disease [48]. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.